TOKYO, JAPAN & BOSTON, MASS -- Perseus Proteomics Inc. (PPMX) and Brigham and Women's Hospital (BWH), announced today that they have signed a research agreement to investigate the plasma pentraxin 3 (PTX3) as a potential predictor of cardiovascular risk in patients.
